{
  "meta": {
    "title": "Disorders_Of_Intermediary_Metabolism",
    "url": "https://brainandscalpel.vercel.app/disorders-of-intermediary-metabolism-66f2b6d7.html",
    "scrapedAt": "2025-11-30T11:12:51.757Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked dominant</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondrial inheritance</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the mode of inheritance of haemochromatosis?</span></p>",
      "unique_key": "DT1198125",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198125,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Hereditary hemochromatosis</strong> is most commonly inherited in an autosomal recessive pattern due to HFE gene mutations on chromosome 6.</p>\n<p><strong>Haemochromatosis: features</strong></p>\n<ul>\n<li>Haemochromatosis is an autosomal recessive disorder of iron absorption and metabolism resulting in iron accumulation. It is caused most commonly by inheritance of mutations in the HFE gene on both copies of chromosome 6.</li>\n</ul>\n<p><strong>Epidemiology</strong></p>\n<ul>\n<li>1 in 10 people of European descent carry a gene mutation affecting iron metabolism, mainly HFE</li>\n<li>prevalence in people of European descent = 1 in 200</li>\n</ul>\n<p><strong>Clinical features</strong></p>\n<ul>\n<li>Early symptoms include fatigue, erectile dysfunction and arthralgia (often of the hands)</li>\n<li>'bronze' skin pigmentation</li>\n<li>diabetes mellitus</li>\n<li>liver: stigmata of chronic liver disease, hepatomegaly, cirrhosis, hepatocellular deposition)</li>\n<li>cardiac failure (2&deg; to dilated cardiomyopathy)</li>\n<li>hypogonadism (2&deg; to cirrhosis and pituitary dysfunction - hypogonadotropic hypogonadism)</li>\n<li>arthritis (especially of the hands)</li>\n</ul>\n<p><strong>Reversible complications Irreversible complications</strong></p>\n<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d19tx39t2q3u48.cloudfront.net/NEETPGMCQ/a0a55905-62f7-4b00-8bee-883c39fabf0f.png\">\n<p>Whilst elevated liver function tests and hepatomegaly may be reversible, cirrhosis is not.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>X-linked dominant (Option B):</strong> No X-linked pattern is associated with HFE mutations.</p>\n<p><strong>Mitochondrial inheritance (Option C):</strong>Mitochondrial disorders are maternally inherited; not relevant to iron metabolism disorders.</p>\n<p><strong>Autosomal dominant (Option D):</strong> Although heterozygous carriers may have mild biochemical abnormalities, clinical disease occurs <strong>only in homozygotes</strong> (recessive).</p>\n<p><strong>Key Takeaway:</strong> <strong>Hereditary hemochromatosis</strong> is an <strong>autosomal recessive disorder</strong> due to <strong>HFE mutations</strong>, leading to progressive iron overload and multisystem complications.</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum thyroxine</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum calcium</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">24-h urine test for 5-hydroxyindoleacetic acid</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">24-hour urinary catecholamines</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old woman presents with recurrent episodes of headaches and sweating. Her mother had renal calculi and died of a tumour in her neck. On examination a nodule is felt in the patient's neck in the region of the thyroid gland. A surgeon advises complete thyroidectomy. What is the most important investigation the surgeon must undertake before surgery?</span></p>",
      "unique_key": "DT1198129",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198129,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Pheochromocytoma must be ruled out prior to thyroidectomy</strong> in suspected <strong>MEN-2A</strong>, as undiagnosed catecholamine excess can lead to <strong>perioperative hypertensive crisis</strong>.<strong><br /> </strong>This patient likely has <strong>MEN-2A</strong>, characterized by:</p>\n<ul>\n<li>Medullary thyroid carcinoma (MTC)</li>\n<li>Pheochromocytoma</li>\n<li>Parathyroid hyperplasia or adenoma</li>\n</ul>\n<p>The presence of <strong>thyroid nodule</strong>, <strong>family history</strong>, and <strong>symptoms of catecholamine excess</strong> (headaches, sweating) strongly suggests <strong>MEN-2A</strong>.</p>\n<ul>\n<li>Most crucial preoperative step: Exclude pheochromocytoma</li>\n<li>Investigations:\n<ul>\n<li>24-hour urinary catecholamines or metanephrines</li>\n<li>If positive &rarr; preoperative alpha-blockade (phenoxybenzamine)</li>\n<li>Only then is thyroid surgery safe</li>\n</ul>\n</li>\n</ul>\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li>\n<p><strong>MEN-2A</strong>:</p>\n<ul>\n<li>Parathyroid hyperplasia</li>\n<li>Medullary carcinoma of thyroid</li>\n<li>Pheochromocytoma</li>\n</ul>\n</li>\n<li><strong>MEN-2B</strong>:\n<ul>\n<li>Medullary carcinoma thyroid</li>\n<li>Pheochromocytoma</li>\n<li><strong>Mucosal neuromas</strong>, <strong>marfanoid habitus</strong></li>\n</ul>\n</li>\n<li><strong>MEN-1</strong>:\n<ul>\n<li>Pituitary adenoma</li>\n<li>Parathyroid hyperplasia</li>\n<li>Pancreatic neuroendocrine tumors</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Serum thyroxine (Option A):</strong> Not altered in medullary carcinoma; MTC arises from <strong>parafollicular C-cells</strong>, not follicular cells.</p>\n<p><strong>Serum calcium (Option B):</strong> May be elevated if parathyroid disease is present, but <strong>not an emergency concern prior to thyroidectomy</strong>.</p>\n<p><strong>24-h urinary 5-HIAA (Option C):</strong> Used to diagnose <strong>carcinoid syndrome</strong>, not relevant in MEN syndromes or thyroid malignancy.</p>\n<p><strong>Key Takeaway: </strong> Before surgery in suspected MEN-2A, pheochromocytoma must be ruled out to prevent intraoperative hypertensive crises from unopposed catecholamine release.</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasound scan</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal arteriography</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">[131I] metaiodobenzylguanidine (MIBG) scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old man presents with a history of panic attacks, palpitations, sweating, headache and flushing. On examination, his pulse rate is 120 bpm, BP 190/110 mmHg. A blood test shows high levels of noradrenaline. Which of the following tests would be most useful in establishing the diagnosis?</span></p>",
      "unique_key": "DT1198133",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198133,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient most probably has a <strong>pheochromocytoma</strong>. The presence of noradrenaline alone usually indicates an extra-adrenal tumour.</p>\n<ul>\n<li>Scanning with [<sup>131</sup>I] metaiodobenzylguanidine (MIBG) produces specific uptake in sites of sympathetic activity with about 90% success.</li>\n<li>It is particularly useful with extra-adrenal tumours. CT and MRI scans are useful in detecting adrenal tumours.</li>\n<li>An ultrasound scan is the least sensitive modality and is thus not preferred.</li>\n<li>Secondary hypertension may occur due to unilateral renal artery stenosis but is unlikely to be associated with these clinical features.</li>\n</ul>\n<p><strong>Related Important Points:</strong></p>\n<ul>\n<li><strong>MEN-2A:</strong> MTC, pheochromocytoma, parathyroid hyperplasia</li>\n<li><strong>MEN-2B:</strong> MTC, pheochromocytoma, mucosal neuromas, marfanoid habitus</li>\n<li><strong>MEN-1:</strong> Pituitary adenoma, parathyroid hyperplasia, pancreatic tumors</li>\n<li>Other investigations such as serum thyroxine or 5-HIAA are unlikely to be associated with these clinical features.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Ultrasound scan (Option A):</strong> Least sensitive, especially for retroperitoneal or small adrenal tumors</p>\n<p><strong>CT scan (Option B):</strong> Good for adrenal localization but less specific; cannot confirm <strong>functional status</strong></p>\n<p><strong>Renal arteriography (Option C):</strong> Used to evaluate <strong>renal artery stenosis</strong>, not useful for diagnosing catecholamine-secreting tumors</p>\n<p><strong>Key Takeaway: </strong> <strong>MIBG scanning</strong> is the investigation of choice for localizing <strong>extra-adrenal pheochromocytomas</strong>, especially when <strong>noradrenaline is elevated</strong>.</p>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenoxybenzamine</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetolol</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxazosin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 43-year-old woman is diagnosed with pheochromocytoma. Screening with pentagastrin testing suggests that she has medullary thyroid carcinoma, and you plan a thyroidectomy. What anti-hypertensive medication should be started before surgery for a patient with pheochromocytoma?</span></p>",
      "unique_key": "DT1198138",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198138,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Phenoxybenzamine</strong>, a long-acting <strong>non-selective alpha-blocker</strong>, is the first-line agent for <strong>preoperative blood pressure control</strong> in pheochromocytoma.</p>\n<ul>\n<li>Phenoxybenzamine is a more potent alpha-blocker than doxazosin and is the recommended choice for initial anti-hypertensive medication in pheochromocytoma where surgery is contemplated. It should be given in divided doses, at 20 mg initially, increasing to 80 mg.</li>\n<li>Patients should then be considered for additional &beta;-blockade with propranolol, again in divided doses up to 240 mg/day. Always start with a blockade first, as initial use of &beta;-blockers may worsen hypertension. Labetalol is not recommended.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d19tx39t2q3u48.cloudfront.net/NEETPGMCQ/bd5a2aa1-b9e2-4d71-ae70-228830d1f122.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Atenolol (Option B):</strong> A <strong>beta-blocker</strong>; contraindicated as first-line due to risk of <strong>unopposed alpha vasoconstriction</strong></p>\n<p><strong>Labetalol (Option C):</strong> Has both alpha and beta-blocking activity, but <strong>beta effect predominates</strong>, making it <strong>less safe preoperatively</strong></p>\n<p><strong>Doxazosin (Option D):</strong> A <strong>selective alpha-1 blocker</strong>; can be used if phenoxybenzamine is unavailable, but <strong>less effective</strong> for complete pre-op blockade</p>\n<p><strong>Key Takeaway:  </strong> <strong>Phenoxybenzamine</strong> is the <strong>drug of choice</strong> for <strong>preoperative alpha-blockade</strong> in pheochromocytoma to prevent intraoperative hypertensive crisis.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated serum calcium</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated metanephrines</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated thyroxine</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased parathyroid hormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman is being investigated for suspected MEN-2b syndrome. She is also noted to have Marfanoid features. What will be the most characteristic finding in a blood test in this patient?</span></p>",
      "unique_key": "DT1198139",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198139,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>MEN-2B</strong> is classically associated with pheochromocytoma, and hence elevated plasma metanephrines are a hallmark laboratory finding.</p>\n<ul>\n<li><strong>Multiple Endocrine Neoplasia type 2B (MEN-2B)</strong> is a rare, autosomal dominant syndrome that includes:</li>\n<li><strong>Medullary thyroid carcinoma (MTC)</strong>-often aggressive and early onset</li>\n<li><strong>Pheochromocytoma</strong> - causing excess catecholamines &rarr; elevated plasma/urine metanephrines</li>\n<li><strong>Mucosal neuromas</strong> - typically on lips, tongue, conjunctiva</li>\n<li><strong>Marfanoid habitus</strong> - tall, long limbs, high-arched palate</li>\n<li>Parathyroid involvement is <strong>uncommon</strong> (unlike MEN-2A)</li>\n</ul>\n<p>The <strong>most reliable and characteristic lab abnormality</strong> is <strong>elevated metanephrines</strong>, due to catecholamine-secreting tumors.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509184bd6920e-ad0f-459f-aa54-56bb9a79abc2.PNG\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Elevated serum calcium (Option A):</strong> More typical of <strong>MEN-1</strong> or <strong>MEN-2A</strong> due to <strong>parathyroid hyperplasia</strong>, not MEN-2B.</p>\n<p><strong>Elevated thyroxine (Option C):</strong> Thyroxine is not elevated in <strong>medullary thyroid carcinoma</strong>, as it arises from <strong>parafollicular C-cells</strong>, not follicular cells.</p>\n<p><strong>Decreased parathyroid hormone (Option D):</strong> MEN-2B does <strong>not cause hypoparathyroidism</strong>; parathyroid abnormalities are uncommon.</p>\n<p><strong>Key Takeaway: </strong> <strong>MEN-2B</strong> features <strong>marfanoid habitus</strong>, <strong>medullary thyroid carcinoma</strong>, and <strong>pheochromocytoma</strong>, with <strong>elevated metanephrines</strong> as the key diagnostic lab clue.</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan of the brain</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver biopsy</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum ceruloplasmin level</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">CRP level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old man presents with a 3-month history of deteriorating physical performance at work, associated with dysarthria and clumsiness. On examination, he looks pale, has hepatomegaly and Kayser-Fleischer rings in the cornea. What would be the most important investigation to support the suspected clinical diagnosis?</span></p>",
      "unique_key": "DT1198145",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198145,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Liver biopsy with quantitative copper estimation (&gt;250 &micro;g/g dry weight) is the most definitive test to confirm Wilson disease. This patient has classic features of Wilson disease, a disorder of impaired copper excretion, due to ATP7B mutation.</p>\n<p>Key findings:</p>\n<ul>\n<li>Neurological signs (dysarthria, clumsiness)</li>\n<li>Hepatomegaly</li>\n<li>KF rings, seen in &gt;99% with neuro features</li>\n</ul>\n<p>According to both Harrison 21st ed and the diagnostic algorithm, if ceruloplasmin is low and KF rings are present with elevated 24-hr urinary copper:</p>\n<ul>\n<li>Liver biopsy is performed to confirm diagnosis, showing:\n<ul>\n<li>Liver copper &gt;250 &micro;g/g dry weight</li>\n<li>Histology consistent with copper accumulation (rhodanine stain)</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d19tx39t2q3u48.cloudfront.net/NEETPGMCQ/c1161c46-47ea-43ac-ab0d-ccd0fb103200.png\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240627606f1404-3c35-441c-a837-1a81518e0afd.jpg\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>CT scan of the brain (Option A):</strong> May show basal ganglia changes, but not diagnostic for Wilson disease</p>\n<p><strong>Serum ceruloplasmin level (Option C): </strong>Often decreased, but low in only ~90%; not confirmatory alone</p>\n<p><strong>CRP level (Option D):</strong> Irrelevant to diagnosis; nonspecific inflammatory marker</p>\n<p><strong>Key Takeaway:</strong> Liver biopsy with copper quantification is the most definitive investigation for confirming Wilson disease, especially when KF rings and neurologic signs are present.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Due to half-normal level of HMB-synthase activity</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Common in Scandinavia & Great Britain</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Almost always latent before puberty</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false about acute intermittent porphyria (AIP)?</span></p>",
      "unique_key": "DT1198151",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198151,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Acute intermittent porphyria (AIP)</strong> is an <strong>autosomal dominant</strong> disorder of <strong>hepatic heme synthesis</strong>, <strong>not recessive</strong>. It is caused by a deficiency of the enzyme <strong>porphobilinogen deaminase</strong> (also called hydroxymethylbilane synthase or HMB-synthase), leading to the accumulation of porphyrin precursors.</p>\n<ul>\n<li>Characterized by <strong>intermittent neurovisceral attacks</strong>: abdominal pain, neuropsychiatric features, seizures</li>\n<li>Symptoms are <strong>often precipitated</strong> by drugs (e.g. barbiturates, phenytoin), infections, hormonal changes, fasting, and stress</li>\n<li><strong>Urinary porphobilinogen (PBG)</strong> increases during and between attacks</li>\n<li><strong>Photosensitivity is not typical</strong> (unlike other porphyrias)</li>\n<li><strong>Urine may turn dark red on standing</strong></li>\n</ul>\n<p><strong>Related Important Points:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509184bdf2cf9-277d-4d6f-bf56-bc2eced863fe.PNG\">\n<p><strong>Key Takeaway: Acute intermittent porphyria (AIP)</strong> is an autosomal dominant disorder of heme synthesis with neurovisceral symptoms and red urine, triggered by environmental and hormonal factors.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute intermittent porphyria (AIP)</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary coproporphyria (HCP)</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Variegate porphyria (VP)</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hepatic porphyrias present during adult life?</span></p>",
      "unique_key": "DT1198152",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198152,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>AIP, HCP, and VP</strong> are all <strong>acute hepatic porphyrias</strong> that <strong>present in adult life</strong> with neurovisceral symptoms and elevated porphyrin precursors.</p>\n<p><strong>Hepatic porphyrias</strong> are disorders caused by enzymatic defects in the <strong>heme biosynthesis pathway</strong> in the liver. The four acute hepatic porphyrias include:</p>\n<ul>\n<li><strong>Acute intermittent porphyria (AIP)</strong></li>\n<li><strong>Hereditary coproporphyria (HCP)</strong></li>\n<li><strong>Variegate porphyria (VP)</strong></li>\n<li><strong>ALA-dehydratase porphyria (ADP)</strong> - rarer, may present in infancy or adolescence</li>\n<li>These porphyrias typically <strong>manifest after puberty</strong>, most often in <strong>early adulthood</strong></li>\n<li>Clinical features include:\n<ul>\n<li><strong>Acute neurovisceral attacks</strong> (abdominal pain, seizures, confusion)</li>\n<li><strong>Autonomic instability</strong> (tachycardia, hypertension)</li>\n<li>In <strong>HCP and VP</strong>, photosensitivity may also be seen</li>\n</ul>\n</li>\n<li>Diagnosis is made by detecting elevated <strong>aminolevulinic acid (ALA)</strong> and <strong>porphobilinogen (PBG)</strong> in urine</li>\n<li>Common triggers: <strong>Drugs, stress, fasting, hormonal shifts, infection</strong></li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>AIP (Option A):</strong> Most common acute hepatic porphyria, presents in <strong>adult females</strong></p>\n<p><strong>HCP (Option B):</strong> Manifests with both <strong>cutaneous and neurovisceral symptoms</strong> in adults</p>\n<p><strong>VP (Option C):</strong> Similar presentation, with cutaneous and neurological involvement in adulthood</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>All three</strong> - AIP, HCP, and VP- are <strong>hepatic porphyrias</strong> that <strong>present during adult life</strong>, often triggered by environmental or hormonal stressors.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">International Prognostic Index (IPI)</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Hasford prognostic system</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Nottingham prognostic index</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Nazer prognostic index</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following best relates to Wilson's disease?</span></p>",
      "unique_key": "DT1198153",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198153,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The <strong>Nazer index</strong> is the <strong>specific prognostic tool</strong> for <strong>Wilson's disease</strong>, especially in <strong>acute liver failure</strong>, guiding decisions regarding <strong>liver transplantation</strong>.<strong><br /> </strong>The <strong>Nazer prognostic index</strong> is used to <strong>assess prognosis in Wilson's disease with fulminant hepatic failure</strong>.</p>\n<ul>\n<li>It includes 3 parameters:\n<ul>\n<li><strong>Serum bilirubin</strong></li>\n<li><strong>AST (Aspartate aminotransferase)</strong></li>\n<li><strong>Prothrombin time prolongation (seconds)</strong></li>\n</ul>\n</li>\n<li><strong>Scoring interpretation:</strong>\n<ul>\n<li>Score &lt;7 &rarr; <strong>Medical management usually sufficient</strong></li>\n<li>Score &ge;9 &rarr; <strong>Indication for urgent liver transplantation</strong></li>\n</ul>\n</li>\n</ul>\n<p>It helps in <strong>timely transplant referral</strong>, especially in <strong>young patients presenting with rapid deterioration</strong> and <strong>encephalopathy</strong>.</p>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>International Prognostic Index (IPI) (Option A):</strong> Used for <strong>non-Hodgkin lymphoma</strong> prognosis.</p>\n<p><strong>Hasford prognostic system (Option B):</strong> Designed for <strong>chronic myeloid leukemia</strong>.</p>\n<p><strong>Nottingham prognostic index (Option C):</strong> Applied in <strong>breast cancer</strong>, based on tumor size, grade, and lymph node involvement.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The <strong>Nazer index</strong> is a validated prognostic tool in <strong>Wilson's disease</strong>, helping assess severity and guide transplant decisions.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Porphyria cutanea tarda (PCT)</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute intermittent porphyria (AIP)</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary coproporphyria (HCP)</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Variegate porphyria (VP)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most common porphyria?</span></p>",
      "unique_key": "DT1198154",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198154,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>PCT</strong> is the <strong>most prevalent porphyria worldwide</strong>, and it primarily presents with <strong>photosensitive skin lesions</strong>.<strong>  </strong> <strong>Porphyrias</strong> are classified based on the site of heme precursor accumulation:</p>\n<ul>\n<li><strong>Hepatic porphyrias</strong>: AIP, HCP, VP, PCT</li>\n<li><strong>Erythropoietic porphyrias</strong>: Congenital erythropoietic porphyria, erythropoietic protoporphyria</li>\n</ul>\n<p><strong>Porphyria cutanea tarda (PCT)</strong> is the:</p>\n<ul>\n<li><strong>Most common porphyria overall</strong></li>\n<li>Caused by a deficiency of <strong>uroporphyrinogen decarboxylase</strong></li>\n<li>Precipitated by: alcohol, hepatitis C, estrogens, iron overload</li>\n</ul>\n<p><strong>Clinical features</strong>:</p>\n<ul>\n<li><strong>Chronic blistering photosensitivity</strong> on sun-exposed areas (esp. dorsum of hands and face)</li>\n<li>Hyperpigmentation, skin fragility, and sclerodermoid changes</li>\n<li>No abdominal or neurologic symptoms (unlike AIP)</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Acute intermittent porphyria (AIP) (Option B):</strong> Most common <strong>acute hepatic porphyria</strong>, but <strong>not the most common overall</strong>.</p>\n<p><strong>Hereditary coproporphyria (HCP) (Option C):</strong> Rare, presents with <strong>neurovisceral and cutaneous</strong> symptoms.</p>\n<p><strong>Variegate porphyria (VP) (Option D):</strong> Also less common, with mixed features but not the most prevalent.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Porphyria cutanea tarda (PCT)</strong> is the <strong>most common porphyria</strong>, characterized by <strong>blistering photosensitivity</strong> and <strong>cutaneous findings</strong>.</p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}